- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
CVS Health Outperforms XWELL in Financial Metrics
Analysts see greater upside potential in CVS Health stock compared to XWELL
Apr. 15, 2026 at 8:08pm
Got story updates? Submit your updates here. ›
A detailed look at the inner workings of the healthcare finance industry reveals the stark contrast between the scale and stability of CVS Health versus the smaller XWELL.NYC TodayCVS Health (NYSE:CVS) and XWELL (NASDAQ:XWEL) are both medical companies, but a comparison of their financial performance and analyst recommendations shows CVS Health is the stronger stock. CVS Health has higher revenue, earnings, and institutional ownership, as well as a more favorable consensus rating and greater potential upside from analysts.
Why it matters
This analysis provides investors with a clear picture of the relative financial health and growth prospects of these two healthcare companies, helping them make more informed investment decisions. The contrast highlights CVS Health's advantages in scale, profitability, and market confidence compared to the smaller XWELL.
The details
CVS Health has higher revenue and earnings than XWELL, and is trading at a lower price-to-earnings ratio, indicating it is the more affordable of the two stocks. CVS Health also has much stronger institutional ownership at 80.7% compared to just 8.7% for XWELL, suggesting large investors see more long-term potential in CVS Health. Analysts also have a more favorable consensus rating and higher average price target for CVS Health, believing it has 26.4% upside potential compared to XWELL.
- The data and analysis is current as of April 15, 2026.
The players
CVS Health Corporation
A large healthcare company that provides health solutions in the United States, operating through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments.
XWELL, Inc.
A smaller company that provides health and wellness services in airport and off-airport marketplaces in the United States and internationally, operating through XpresSpa, XpresTest, Naples Wax Center, and Treat segments.
The takeaway
This analysis highlights CVS Health's significant advantages over XWELL in terms of scale, profitability, institutional backing, and analyst sentiment. Investors seeking exposure to the healthcare sector may find CVS Health to be the more attractive and lower-risk investment option compared to the smaller and less established XWELL.
